MedTrace Logo

Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis

NCT01760577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2013-01-04

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of intraarticular Botulinum Toxin A versus intraarticular hyaluronate plus rehabilitation exercise in patients with ankle osteoarthritis.

Conditions

  • Ankle Osteoarthritis

Interventions

DRUG

Botulinum Toxin A (Allergan, Inc, Irvine CA)

patients received intraarticular injections by the same experienced physician using aseptic procedures.

DRUG

Hyalgan (Hyalgan, Fidia , Italy)

The rehabilitation program consists of 6 sessions of rehabilitation exercise for 50 miniutes/day, 3 days per week for 2 weeks and home exercise program for another 2 weeks.

Sponsors & Collaborators

  • Kaohsiung Veterans General Hospital.

    lead OTHER

Principal Investigators

  • Shu-Fen Sun, MD · Kaohsiung Veterans General Hospital, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-05-31
Completion
2012-11-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01760577 on ClinicalTrials.gov